Elevated levels of fibrinogen-derived endogenous citrullinated peptides in synovial fluid of rheumatoid arthritis patients

Arthritis Research and Therapy

Volumn 14, Issue 3, 2012, Pages

  Raijmakers, Reinout ^a   van Beers, Joyce J B C ^b   El Azzouny, Mahmoud ^a   Visser, Natasja F C ^a   Božič, Borut ^c   Pruijn, Ger J M ^b   Heck, Albert J R ^a  

^a NETHERLANDS PROTEOMICS CENTRE   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

CITRULLINATED PEPTIDE; CITRULLINE; FIBRINOGEN; PEPTIDE; SERINE; UNCLASSIFIED DRUG; AUTOANTIGEN;

ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL ARTICLE; FEMALE; FILTRATION; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; OCHRONOSIS; OSTEOARTHRITIS; PEPTIDE ANALYSIS; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SOLID PHASE EXTRACTION; SYNOVIAL FLUID; CHEMISTRY; IMMUNOLOGY; METABOLISM;

ARTHRITIS, RHEUMATOID; AUTOANTIGENS; CHROMATOGRAPHY, LIQUID; CITRULLINE; FIBRINOGEN; HUMANS; MASS SPECTROMETRY; PEPTIDES; SYNOVIAL FLUID;

EID: 84860802462     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3840     Document Type: Article

References (26)

1. Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T, Serre G. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol 2001, 166:4177-4184.
2. Matsuo K, Xiang Y, Nakamura H, Masuko K, Yudoh K, Noyori K, Nishioka K, Saito T, Kato T. Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach. Arthritis Res Ther 2006, 8:R175. 10.1186/ar2085, 1794520, 17125526.
3. Takizawa Y, Suzuki A, Sawada T, Ohsaka M, Inoue T, Yamada R, Yamamoto K. Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids. Ann Rheum Dis 2006, 65:1013-1020. 10.1136/ard.2005.044743, 1798256, 16449316.
4. van Venrooij WJ, van Beers JJ, Pruijn GJ. Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis. Ann N Y Acad Sci 2008, 1143:268-285. 10.1196/annals.1443.013, 19076355.
5. Pruijn GJ, Wiik A, van Venrooij WJ. The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis. Arthritis Res Ther 2010, 12:203. 10.1186/ar2903, 2875630, 20236483.
6. Sebbag M, Moinard N, Auger I, Clavel C, Arnaud J, Nogueira L, Roudier J, Serre G. Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins. Eur J Immunol 2006, 36:2250-2263. 10.1002/eji.200535790, 16838278.
7. Wolberg AS. Thrombin generation and fibrin clot structure. Blood Rev 2007, 21:131-142. 10.1016/j.blre.2006.11.001, 17208341.
8. Hill JA, Bell DA, Brintnell W, Yue D, Wehrli B, Jevnikar AM, Lee DM, Hueber W, Robinson WH, Cairns E. Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J Exp Med 2008, 205:967-979. 10.1084/jem.20072051, 2292232, 18391064.
9. Snir O, Widhe M, von Spee C, Lindberg J, Padyukov L, Lundberg K, Engstrom A, Venables PJ, Lundeberg J, Holmdahl R, Klareskog L, Malmström V. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles. Ann Rheum Dis 2009, 68:736-743. 10.1136/ard.2008.091355, 18635594.
10. Holoshitz J. The rheumatoid arthritis HLA-DRB1 shared epitope. Curr Opin Rheumatol 2010, 22:293-298. 10.1097/BOR.0b013e328336ba63, 2921962, 20061955.
11. Ho PP, Lee LY, Zhao X, Tomooka BH, Paniagua RT, Sharpe O, BenBarak MJ, Chandra PE, Hueber W, Steinman L, Robinson WH. Autoimmunity against fibrinogen mediates inflammatory arthritis in mice. J Immunol 2010, 184:379-390. 10.4049/jimmunol.0901639, 19949094.
12. Willis VC, Gizinski AM, Banda NK, Causey CP, Knuckley B, Cordova KN, Luo Y, Levitt B, Glogowska M, Chandra P, Kulik L, Robinson WH, Arend WP, Thompson PR, Holers VM. N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis. J Immunol 2011, 186:4396-4404. 10.4049/jimmunol.1001620, 3085980, 21346230.
13. Zhao X, Okeke NL, Sharpe O, Batliwalla FM, Lee AT, Ho PP, Tomooka BH, Gregersen PK, Robinson WH. Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Res Ther 2008, 10:R94. 10.1186/ar2478, 2575608, 18710572.
14. Clavel C, Nogueira L, Laurent L, Iobagiu C, Vincent C, Sebbag M, Serre G. Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen. Arthritis Rheum 2008, 58:678-688. 10.1002/art.23284, 18311806.
15. Kamphorst JJ, van der Heijden R, DeGroot J, Lafeber FP, Reijmers TH, van El B, Tjaden UR, van der Greef J, Hankemeier T. Profiling of endogenous peptides in human synovial fluid by NanoLC-MS: method validation and peptide identification. J Proteome Res 2007, 6:4388-4396. 10.1021/pr0704534, 17929855.
16. von Delwig A, Locke J, Robinson JH, Ng WF. Response of Th17 cells to a citrullinated arthritogenic aggrecan peptide in patients with rheumatoid arthritis. Arthritis Rheum 2010, 62:143-149.
17. Gibson DS, Rooney ME. The human synovial fluid proteome: A key factor in the pathology of joint disease. Proteomics Clin Appl 2007, 1:889-899. 10.1002/prca.200700044, 21136742.
18. Raijmakers R, Zendman AJ, Egberts WV, Vossenaar ER, Raats J, Soede-Huijbregts C, Rutjes FP, van Veelen PA, Drijfhout JW, Pruijn GJ. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro. J Mol Biol 2007, 367:1118-1129. 10.1016/j.jmb.2007.01.054, 17303166.
19. Beranova-Giorgianni S, Zhao Y, Desiderio DM, Giorgianni F. Phosphoproteomic analysis of the human pituitary. Pituitary 2006, 9:109-120. 10.1007/s11102-006-8916-x, 16807684.
20. Linding R, Jensen LJ, Ostheimer GJ, van Vugt MA, Jorgensen C, Miron IM, Diella F, Colwill K, Taylor L, Elder K, Metalnikov P, Nguyen V, Pasculescu A, Jin J, Park JG, Samson LD, Woodgett JR, Russell RB, Bork P, Yaffe MB, Pawson T. Systematic discovery of in vivo phosphorylation networks. Cell 2007, 129:1415-1426. 10.1016/j.cell.2007.05.052, 2692296, 17570479.
21. Tabushi Y, Nakanishi T, Takeuchi T, Nakajima M, Ueda K, Kotani T, Makino S, Shimizu A, Hanafusa T, Takubo T. Detection of citrullinated proteins in synovial fluids derived from patients with rheumatoid arthritis by proteomics-based analysis. Ann Clin Biochem 2008, 45:413-417. 10.1258/acb.2007.007205, 18583628.
22. van Beers JJ, Raijmakers R, Alexander LE, Stammen-Vogelzangs J, Lokate AM, Heck AJ, Schasfoort RB, Pruijn GJ. Mapping of citrullinated fibrinogen B-cell epitopes in rheumatoid arthritis by imaging surface plasmon resonance. Arthritis Res Ther 2010, 12:R219. 10.1186/ar3205, 3046532, 21182780.
23. Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 2003, 25:1106-1118. 10.1002/bies.10357, 14579251.
24. Rawlings ND, Barrett AJ, Bateman A. MEROPS: the peptidase database. Nucleic Acids Res 2009, 38:D227-233. 2808883, 19892822.
25. Nakayama-Hamada M, Suzuki A, Furukawa H, Yamada R, Yamamoto K. Citrullinated fibrinogen inhibits thrombin-catalysed fibrin polymerization. J Biochem 2008, 144:393-398. 10.1093/jb/mvn079, 18583356.
26. Simon DI, Ezratty AM, Loscalzo J. The fibrin(ogen)olytic properties of cathepsin D. Biochemistry 1994, 33:6555-6563. 10.1021/bi00187a024, 8204591.